Log in to save to my catalogue

SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress...

SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A627358438

SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-?B p65 translocation

About this item

Full title

SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-?B p65 translocation

Publisher

BioMed Central Ltd

Journal title

Respiratory research, 2020-05, Vol.21 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Background It has been confirmed that NF-?B p65 signaling pathway is involved in the regulation of alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome (ARDS). Whether SN50, a NF-?B cell permeable inhibitor, could attenuate alveolar hypercoagulation and fibrinolysis inhibition in ARDS remains to be elucidated...

Alternative Titles

Full title

SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-?B p65 translocation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A627358438

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A627358438

Other Identifiers

ISSN

1465-9921

DOI

10.1186/s12931-020-01372-6

How to access this item